Milbank

Special Counsel, Litigation & Arbitration Group

Mr. Rosenthal is widely considered a "go-to" practitioner for government merger and non-merger investigations, as well as counseling on antitrust issues, with a proven track record advising clients on complex cross-border transactions with multiple merger clearance requirements. He has broad experience handling complex antitrust issues in a variety of industries, including healthcare, pharmaceuticals, biotechnology, manufacturing, oil & gas, solid waste, transportation, automobile components, semiconductors, software, hardware, chemicals, publishing, renewable energy, entertainment, and retail sales.

Mr. Rosenthal has successfully defended non-merger investigations, including investigations of violations of Section 8 of the Clayton Act, and has advocated for government intervention on behalf of parties adversely impacted by proposed mergers. He also advises clients on issues relating to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as well as international merger notification requirements. Clients turn to Mr. Rosenthal on a variety of antitrust risk management issues relating to business initiatives such as joint ventures, pricing and distribution strategies, information and data-sharing, and trade association and industry-wide collaborative efforts.

Mr. Rosenthal received his J.D. from the University of Virginia School of Law and his B.A. from Emory University.